JAZZ Jazz Pharmaceuticals plc - Ordinary Shares
$256,92
Harga · Agu 19, 2026
Fundamental per Agu 3, 2026
Rentang 52M
$118–$265
94% of range
Peringkat Analis
BUY
26 analysts
Target Harga
$281
+9% upside
P/E (TTM)
-29.1
ROE
—
Margin Laba Bersih
—
Tentang Jazz Pharmaceuticals plc - Ordinary Shares Tinjauan perusahaan dari Wikipedia
Jazz Pharmaceuticals plc is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Baca selengkapnya
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem (sodium oxybate), the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid (GHB). In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness (EDS) in narcolepsy as well as obstructive sleep apnea (OSA). In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals.
In 2007, the company pled guilty to felony charges related to its illegal marketing of Xyrem for off-label use.
The company is also a member of the Pharmaceutical Research and Manufacturers of America (PhRMA).
Company history and acquisitions
2010–2019
On 18 February 2010, the FDA accepted a new drug application for JZP-6 (Sodium oxybate) for the treatment of Fibromyalgia. In the following December, a new patent was issued for Sodium Oxybate.
On September 19, 2011, Jazz Pharmaceuticals merged with Irish Azur Pharma plc to form Jazz Pharmaceuticals plc. The Azur Pharma seat in Dublin became the headquarters of the combined company. Azur Pharma had been marketing specialty pharmaceutical products in the central nervous system (CNS) and women's health areas with US operations in Philadelphia.
On 26 April 2012, the company acquired EUSA Pharma for $650 million (plus $50 million in milestone payments). In September, the company sold its Women's Health business to Meda for $95 million. In December, the company began clinical trial of intravenous Erwinaze in patients with Acute Lymphoblastic Leukemia.
In January 2014, the company announced it would acquire the rare disease drug developer Gentium SpA and its lead product Defitelio for $1 billion.
In May 2016, the company announced it would acquire Alizé Pharma II for $20.5 million. At the end of the same month, the company announced its then largest acquisition, with the purchase of Celator Pharmaceuticals for $1.5 billion. As a result, Jazz obtained the rights to breakthrough therapy Vyxeos (liposomal daunorubicin and cytarabine) for treatment of acute myeloid leukemia.
In August 2019, the company announced it would acquire Cavion Inc. for up to $310 million.
2020–present
In January 2021, Jazz announced it would acquire cannabis-focused medicinal drug company GW Pharmaceuticals for US$7.2 billion. This acquisition added the medication Epidiolex (cannabidiol), developed to treat severe epilepsy syndromes, to the company's portfolio.
In November 2025, Jazz Pharmaceuticals announced positive results from its Phase 3 trial for its cancer drug, Ziihera, a potential treatment for advanced gastroesophageal cancer.
Acquisition history
The following is an illustration of the company's mergers, acquisitions, spin-offs and historical predecessors:
== References ==
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
JAZZ Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$256.92
Kapitalisasi Pasar
—
P/E (TTM)
-29.1
EPS (TTM)
$-5.84
Pendapatan (TTM)
$4.27B
Imbal Hasil Dividen
—
ROE
—
D/E Utang/Ekuitas
—
Rentang 52M
$118 – $265
JAZZ Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
$4.27B
2016-12-31
→
2025-12-31
EPS
$-5.84
2016-12-31
→
2025-12-31
Arus Kas Bebas
—
Margin
—
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
JAZZ
Median Rekan
P/E (TTM)
-29.1
530.6
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
JAZZ
Median Rekan
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
JAZZ
Median Rekan
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
JAZZ
Median Rekan
Revenue YoY (Pendapatan YoY)
4.9%
—
Revenue CAGR 3Y (CAGR Pendapatan 3T)
5.3%
—
Revenue CAGR 5Y (CAGR Pendapatan 5T)
12.5%
—
EPS YoY
41.8%
—
Net Income YoY (Laba Bersih YoY)
35.0%
—
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
JAZZ
Median Rekan
JAZZ Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
26 analis
- Beli Kuat 7 26,9%
- Beli 17 65,4%
- Tahan 2 7,7%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
20 analis · 2026-08-15
Median
$285.00
Sekarang
$256.92
Rendah
$196.00
Tinggi
$315.00
Target median
$285.00
+10,9%
Target rata-rata
$281.10
+9,4%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-0.06%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $5.71 | $6.30 | -0.59% |
| 31 Maret 2026 | $6.34 | $4.66 | 1.7% |
| 31 Des. 2025 | $6.64 | $6.65 | -0.01% |
| 30 Sep. 2025 | $8.13 | $6.04 | 2.1% |
| 30 Juni 2025 | $-8.25 | $-7.76 | -0.49% |
| 31 Maret 2025 | $1.68 | $4.75 | -3.1% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| JAZZ | — | -29.1 | 4.9% | — | — | — |
| GHRS | — | — | — | — | — | — |
| PRGO | $1.92B | -1.4 | -2.8% | -33.5% | -38.5% | 35.1% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 14
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B | $2.36B | $2.16B | $1.89B | $1.62B | $1.49B | $1.32B | $1.17B | |
| R&D Expense | · | · | · | · | · | · | $300M | $227M | $198M | $162M | $135M | $85M | |
| SG&A Expense | $1.81B | $1.39B | $1.34B | $1.42B | $1.45B | $854M | $737M | $684M | $544M | $503M | $449M | $406M | |
| Operating Expenses | $4.70B | $3.35B | $3.26B | $3.72B | $2.92B | $1.99B | $1.63B | $1.28B | $1.09B | $896M | $817M | $977M | |
| Operating Income | $-430M | $717M | $579M | $-66M | $170M | $378M | $532M | $615M | $529M | $592M | $508M | $196M | |
| Interest Income | $86M | $106M | $65M | $12M | $2M | $11M | $20M | $17M | $4M | · | · | · | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $1M | $9M | |
| Pretax Income | $-628M | $470M | $298M | $-373M | $-113M | $275M | $454M | $529M | $441M | $532M | $436M | $152M | |
| Income Tax | $-272M | $-91M | $-120M | $-159M | $216M | $34M | $-73M | $80M | $-48M | $135M | $106M | $94M | |
| Net Income | $-356M | $560M | $415M | $-224M | $-330M | $239M | $523M | $447M | $488M | $397M | $330M | $58M | |
| EPS (Basic) | $-5.84 | $9.06 | $6.55 | $-3.58 | $-5.52 | $4.28 | $9.22 | $7.45 | $8.13 | $6.56 | $5.38 | $0.98 | |
| EPS (Diluted) | $-5.84 | $8.65 | $6.10 | $-3.58 | $-5.52 | $4.22 | $9.09 | $7.30 | $7.96 | $6.41 | $5.23 | $0.93 | |
| Shares (Basic) | 60,981,000 | 61,838,000 | 63,291,000 | 62,539,000 | 59,694,000 | 55,712,000 | 56,749,000 | 59,976,000 | 60,018,000 | 60,500,000 | 61,232,000 | 59,746,000 | |
| Shares (Diluted) | 60,981,000 | 66,007,000 | 72,066,000 | 62,539,000 | 59,694,000 | 56,517,000 | 57,550,000 | 61,221,000 | 61,317,000 | 61,870,000 | 63,036,000 | 62,614,000 |
Neraca 26
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.39B | $2.41B | $1.51B | $881M | $591M | $1.06B | $637M | $310M | $386M | $366M | $989M | $684M | |
| Receivables | $831M | $717M | $706M | $651M | $563M | $396M | $356M | $264M | $224M | $234M | $210M | $186M | |
| Inventory | $417M | $480M | $597M | $714M | $1.07B | $95M | $79M | $53M | $43M | $34M | $19M | $30M | |
| Prepaid Expense | $152M | $177M | $185M | $92M | $131M | $62M | $39M | $25M | $23M | $25M | $21M | $13M | |
| Other Current Assets | $324M | $262M | $321M | $267M | $252M | $152M | $79M | $68M | $77M | $29M | $19M | $21M | |
| Current Assets | $4.17B | $4.63B | $3.44B | $2.61B | $2.61B | $2.84B | $1.63B | $1.23B | $968M | $748M | $1.26B | $1.02B | |
| PP&E (Net) | · | · | · | · | · | $128M | $132M | $200M | $170M | $107M | $86M | $58M | |
| PP&E (Gross) | · | · | · | · | · | $196M | $187M | $250M | $211M | $140M | $109M | $74M | |
| Accum. Depreciation | · | · | · | · | · | $68M | $55M | $50M | $41M | $32M | $24M | $15M | |
| Goodwill | $1.83B | $1.72B | $1.75B | $1.69B | $1.83B | $958M | $920M | $928M | $948M | $894M | $657M | $703M | |
| Intangibles | $4.43B | $4.76B | $5.42B | $5.79B | $7.15B | $2.20B | $2.44B | $2.73B | $2.98B | $3.01B | $1.19B | $1.44B | |
| Other Non-current Assets | $99M | $114M | $67M | $55M | $41M | $26M | $48M | $43M | $16M | $14M | $9M | $16M | |
| Total Assets | $11.66B | $12.01B | $11.39B | $10.84B | $12.30B | $6.54B | $5.54B | $5.20B | $5.12B | $4.80B | $3.33B | $3.34B | |
| Accounts Payable | $122M | $78M | $103M | $91M | $100M | $27M | $46M | $41M | $24M | $22M | $22M | $25M | |
| Accrued Liabilities | $1.03B | $911M | $794M | $803M | $666M | $353M | $270M | $265M | $199M | $193M | $164M | $164M | |
| Current Liabilities | $2.24B | $1.04B | $1.54B | $933M | $809M | $654M | $364M | $345M | $294M | $257M | $227M | $217M | |
| Capital Leases | $51M | $39M | $59M | $72M | $87M | $140M | $151M | $0 | · | · | · | · | |
| Deferred Tax | $594M | $677M | $848M | $944M | $1.30B | $130M | $224M | $309M | $383M | $557M | $283M | $375M | |
| Other Non-current Liabilities | $124M | $87M | $105M | $107M | $117M | $101M | $109M | $219M | $177M | $113M | $69M | $38M | |
| Long-term Debt | $5.36B | $6.11B | $5.71B | $5.72B | $6.05B | $2.09B | $1.61B | $1.60B | $1.58B | $2.03B | $1.19B | $1.34B | |
| Common Stock | $0 | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Retained Earnings | $646M | $1.13B | $879M | $734M | $830M | $1.16B | $1.07B | $841M | $918M | $529M | $303M | $35M | |
| AOCI | $-569M | $-948M | $-842M | $-1.13B | $-400M | $-134M | $-223M | $-198M | $-141M | $-317M | $-267M | $-122M | |
| Stockholders' Equity | $4.32B | $4.09B | $3.74B | $3.09B | $3.97B | $3.66B | $3.11B | $2.76B | $2.71B | $1.88B | $1.71B | $1.37B | |
| Liabilities + Equity | $11.66B | $12.01B | $11.39B | $10.84B | $12.30B | $6.54B | $5.54B | $5.20B | $5.12B | $4.80B | $3.33B | $3.34B | |
| Shares Outstanding | 61,400,000 | 60,600,000 | 62,255,000 | 63,214,000 | 61,633,000 | 56,171,000 | 56,140,000 | 57,704,000 | 58,898,000 | 59,820,000 | 61,305,000 | 60,643,000 |
Arus Kas 12
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $42M | $33M | $30M | $30M | $27M | $19M | $15M | $15M | $13M | $12M | $10M | · | |
| Stock-based Comp | $291M | $248M | $227M | $222M | $189M | $121M | $111M | $102M | $107M | $99M | $92M | $70M | |
| Deferred Tax | $-445M | $-208M | $-260M | $-292M | $69M | $-137M | $-237M | $-89M | $-226M | $-41M | $-68M | $-49M | |
| Amort. of Intangibles | $655M | $627M | $608M | $599M | $526M | $260M | $355M | $201M | $152M | $102M | $98M | $127M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $2M | $2M | |
| Operating Cash Flow | $1.36B | $1.40B | $1.09B | $1.27B | $779M | $900M | $776M | $799M | $693M | $592M | $532M | $408M | |
| CapEx | $59M | $38M | $24M | $29M | $28M | $15M | $40M | $20M | $29M | $10M | $36M | $36M | |
| Investing Cash Flow | $-1.51B | $-508M | $-163M | $-446M | $-5.21B | $-1.01B | $-155M | $-394M | $-269M | $-1.75B | $-2M | $-1.07B | |
| Stock Repurchased | $125M | $311M | $270M | $54.0K | $0 | $147M | $301M | $524M | $99M | $278M | $62M | $42M | |
| Financing Cash Flow | $-873M | $21M | $-305M | $-529M | $3.97B | $528M | $-294M | $-479M | $-409M | $541M | $-214M | $711M | |
| Net Change in Cash | $-1.02B | $907M | $625M | $290M | $-466M | $420M | $328M | $-76M | $20M | $-623M | $305M | $48M | |
| Taxes Paid | $122M | $115M | $178M | · | · | · | · | · | · | · | · | · |
Tingkat Pertumbuhan 7
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.9% | 6.1% | 4.8% | 18.3% | 30.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.3% | 9.6% | 17.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 12.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | 41.8% | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | · | 13.1% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | 35.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | · | 20.2% | · | · | · | · | · | · | · | · | · |
Valuasi (TTM) 5
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B | $2.36B | $2.16B | $1.89B | $1.62B | $1.49B | $1.32B | $1.17B | |
| Net Income TTM | $-356M | $560M | $415M | $-224M | $-330M | $239M | $523M | $447M | $488M | $397M | $330M | $58M | |
| P/E | -29.1 | 14.2 | 20.2 | -44.5 | -23.1 | 39.1 | 16.4 | 17.0 | 16.9 | 17.0 | 26.9 | 176.1 | |
| P / Tangible Book | · | · | · | · | · | 18.3 | · | · | · | · | · | · | |
| Earnings Yield | -3.4% | 7.0% | 5.0% | -2.2% | -4.3% | 2.6% | 6.1% | 5.9% | 5.9% | 5.9% | 3.7% | 0.57% |
Laporan Laba Rugi 13
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.21B | $1.07B | $1.20B | $1.13B | $1.05B | $898M | $1.09B | $1.05B | $1.02B | $902M | $1.01B | $972M | $957M | $893M | $972M | $941M | |
| SG&A Expense | $389M | $353M | $406M | $531M | $358M | $514M | $369M | $326M | $339M | $352M | $396M | $308M | $341M | $298M | $383M | $358M | |
| Operating Expenses | $960M | $732M | $943M | $1.07B | $1.73B | $954M | $897M | $795M | $824M | $836M | $889M | $800M | $800M | $767M | $1.24B | $916M | |
| Operating Income | $248M | $337M | $255M | $58M | $-686M | $-56M | $191M | $260M | $199M | $66M | $122M | $172M | $158M | $126M | $-263M | $25M | |
| Interest Income | $25M | $23M | $20M | $19M | $19M | $28M | $32M | $26M | $25M | $23M | $21M | $19M | $15M | $11M | $7M | $4M | |
| Pretax Income | $211M | $299M | $208M | $9M | $-736M | $-110M | $133M | $201M | $138M | $-2M | $62M | $100M | $82M | $55M | $-340M | $-60M | |
| Income Tax | $18M | $6M | $5M | $-242M | $-17M | $-18M | $-58M | $-15M | $-31M | $12M | $-33M | $-47M | $-24M | $-15M | $-100M | $-43M | |
| Net Income | $193M | $293M | $203M | $251M | $-718M | $-92M | $191M | $215M | $169M | $-15M | $94M | $147M | $104M | $69M | $-241M | $-20M | |
| EPS (Basic) | $3.05 | $4.73 | $3.28 | $4.14 | $-11.74 | $-1.52 | $3.11 | $3.50 | $2.68 | $-0.23 | $1.50 | $2.33 | $1.63 | $1.09 | $-3.86 | $-0.31 | |
| EPS (Diluted) | $2.78 | $4.43 | $3.34 | $4.08 | $-11.74 | $-1.52 | $2.97 | $3.42 | $2.49 | $-0.23 | $1.40 | $2.14 | $1.52 | $1.04 | $-3.85 | $-0.31 | |
| Shares (Basic) | 63,200,000 | 61,900,000 | -121,888,000 | 60,696,000 | 61,200,000 | 61,000,000 | -124,995,000 | 61,414,000 | 62,882,000 | 62,537,000 | -127,308,000 | 63,114,000 | 63,991,000 | 63,494,000 | -124,547,000 | 62,785,000 | |
| Shares (Diluted) | 69,400,000 | 66,100,000 | -122,798,000 | 61,606,000 | 61,200,000 | 61,000,000 | -129,329,000 | 63,174,000 | 69,625,000 | 62,537,000 | -146,538,000 | 71,293,000 | 73,540,000 | 73,771,000 | -126,584,000 | 62,785,000 | |
| EBITDA | $248M | $337M | · | $58M | $-686M | $-56M | · | $260M | $199M | $66M | · | $172M | $158M | $126M | · | $25M |
Neraca 24
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.62B | $1.84B | $1.39B | $1.33B | $1.19B | $1.86B | $2.41B | $2.22B | $1.36B | $1.44B | · | $1.34B | $1.28B | $1.17B | · | $839M | |
| Receivables | $881M | $836M | $831M | $764M | $714M | $653M | $717M | $724M | $698M | $707M | · | $628M | $610M | $624M | · | $601M | |
| Inventory | $443M | $438M | $417M | $483M | $505M | $493M | $480M | $539M | $543M | $577M | · | $612M | $657M | $675M | · | $728M | |
| Prepaid Expense | $200M | $150M | $152M | $147M | $164M | $150M | $177M | $155M | $134M | $123M | · | $110M | $107M | $73M | · | $93M | |
| Other Current Assets | $244M | $285M | $324M | $315M | $298M | $260M | $262M | $354M | $326M | $315M | · | $310M | $272M | $245M | · | $250M | |
| Current Assets | $3.97B | $4.58B | $4.17B | $3.76B | $3.35B | $4.13B | $4.63B | $4.39B | $3.68B | $3.54B | · | $3.25B | $3.01B | $2.78B | · | $2.57B | |
| Goodwill | $1.80B | $1.80B | $1.83B | $1.83B | $1.84B | $1.76B | $1.72B | $1.80B | $1.74B | $1.74B | · | $1.71B | $1.74B | $1.72B | · | $1.59B | |
| Intangibles | $4.03B | $4.20B | $4.43B | $4.57B | $4.77B | $4.72B | $4.76B | $5.14B | $5.08B | $5.24B | · | $5.42B | $5.71B | $5.76B | · | $5.57B | |
| Other Non-current Assets | $86M | $95M | $99M | $103M | $121M | $117M | $114M | $75M | $71M | $71M | · | $76M | $66M | $64M | · | $35M | |
| Total Assets | $11.08B | $11.86B | $11.66B | $11.36B | $10.94B | $11.53B | $12.01B | $12.26B | $11.36B | $11.33B | · | $11.20B | $11.26B | $11.05B | · | $10.38B | |
| Accounts Payable | $128M | $100M | $122M | $152M | $89M | $96M | $78M | $85M | $97M | $81M | · | $110M | $98M | $125M | · | $102M | |
| Accrued Liabilities | $1.03B | $1.02B | $1.03B | $1.00B | $875M | $1.06B | $911M | $859M | $801M | $827M | · | $770M | $748M | $712M | · | $668M | |
| Current Liabilities | $2.23B | $2.25B | $2.24B | $2.27B | $2.07B | $1.22B | $1.04B | $1.03B | $1.56B | $1.56B | · | $1.57B | $945M | $909M | · | $813M | |
| Capital Leases | $44M | $47M | $51M | $53M | $55M | $39M | $39M | $71M | $68M | $56M | · | $62M | $66M | $72M | · | $73M | |
| Deferred Tax | $529M | $548M | $594M | $629M | $682M | $671M | $677M | $792M | $775M | $810M | · | $841M | $911M | $932M | · | $934M | |
| Other Non-current Liabilities | $141M | $162M | $125M | $109M | $94M | $91M | $87M | $111M | $99M | $97M | · | $127M | $127M | $109M | · | $124M | |
| Long-term Debt | $4.35B | $5.35B | $5.36B | $5.36B | $5.36B | $5.37B | $6.11B | $6.11B | $5.71B | $5.71B | · | $5.72B | $5.72B | $5.72B | · | $5.73B | |
| Total Debt | $4.35B | $5.35B | · | $5.36B | $5.36B | $5.37B | · | $6.11B | $5.71B | $5.71B | · | $5.72B | $5.72B | $5.72B | · | $5.73B | |
| Common Stock | $0 | $0 | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Retained Earnings | $1.13B | $939M | $646M | $443M | $191M | $1.03B | $1.13B | $936M | $871M | $864M | · | $884M | $812M | $803M | · | $974M | |
| AOCI | $-662M | $-651M | $-569M | $-570M | $-486M | $-786M | $-948M | $-603M | $-888M | $-882M | · | $-1.04B | $-867M | $-980M | · | $-1.62B | |
| Stockholders' Equity | $4.80B | $4.53B | $4.32B | $3.96B | $3.71B | $4.17B | $4.09B | $4.17B | $3.76B | $3.70B | $3.74B | $3.49B | $3.53B | $3.34B | $3.09B | $2.75B | |
| Liabilities + Equity | $11.08B | $11.86B | $11.66B | $11.36B | $10.94B | $11.53B | $12.01B | $12.26B | $11.36B | $11.33B | · | $11.20B | $11.26B | $11.05B | · | $10.38B | |
| Shares Outstanding | 64,800,000 | 62,700,000 | 61,435,000 | 60,740,000 | 60,640,000 | 61,623,000 | 60,631,000 | 60,443,000 | 61,745,000 | 63,028,000 | 62,255,000 | 62,945,000 | · | · | 63,214,000 | · |
Arus Kas 10
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $73M | $74M | $71M | $88M | $65M | $68M | $70M | $60M | $57M | $61M | $53M | $56M | $61M | $56M | $62M | $57M | |
| Deferred Tax | $-39M | $-66M | $-63M | $-271M | $-66M | $-44M | $-2M | $-64M | $-75M | $-66M | $-36M | $-79M | $-79M | $-66M | $-145M | $-65M | |
| Amort. of Intangibles | $170M | $172M | $170M | $168M | $162M | $154M | $159M | $157M | $155M | $156M | $152M | $155M | $152M | $150M | $137M | $141M | |
| Operating Cash Flow | $416M | $408M | $363M | $475M | $89M | $430M | $399M | $399M | $331M | $267M | $167M | $307M | $297M | $321M | $342M | $418M | |
| CapEx | $18M | $20M | $17M | $15M | $13M | $14M | $13M | $11M | $7M | $7M | $10M | $4M | $6M | $4M | $9M | $-5M | |
| Investing Cash Flow | $355M | $123M | $-372M | $-328M | $-641M | $-169M | $-193M | $214M | $-257M | $-272M | $102M | $-174M | $-86M | $-5M | $-324M | $5M | |
| Stock Repurchased | · | · | $0 | $0 | · | · | $0 | $150M | · | · | $100M | $74M | · | · | $0 | $0 | |
| Financing Cash Flow | $-994M | $-78M | $75M | $-11M | $-125M | $-814M | $-8M | $246M | $-161M | $-57M | $-100M | $-78M | $-97M | $-30M | $20M | $-289M | |
| Net Change in Cash | $-224M | $452M | $66M | $136M | $-672M | $-551M | $195M | $862M | $-88M | $-63M | $171M | $53M | $114M | $286M | $42M | $128M | |
| Free Cash Flow | · | $388M | · | · | · | $416M | · | · | · | $260M | · | · | · | $317M | · | · |
Profitabilitas 7
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 20.5% | 31.5% | · | 5.1% | -65.6% | -6.2% | · | 24.7% | 19.5% | 7.3% | · | 17.7% | 16.5% | 14.1% | · | 2.6% | |
| Net Margin | 16.0% | 27.4% | · | 22.3% | -68.7% | -10.3% | · | 20.4% | 16.5% | -1.6% | · | 15.1% | 10.9% | 7.8% | · | -2.1% | |
| Pretax Margin | 17.5% | 28.0% | · | 0.80% | -70.3% | -12.2% | · | 19.0% | 13.5% | -0.18% | · | 10.2% | 8.5% | 6.2% | · | -6.4% | |
| EBITDA Margin | 20.5% | 31.5% | · | 5.1% | -65.6% | -6.2% | · | 24.7% | 19.5% | 7.3% | · | 17.7% | 16.5% | 14.1% | · | 2.6% | |
| ROA | 1.8% | 2.5% | · | 2.1% | -6.4% | -0.81% | · | 1.8% | 1.5% | -0.13% | · | 1.4% | 0.93% | 0.61% | · | -0.17% | |
| ROE | 4.5% | 6.7% | · | 6.2% | -19.2% | -2.4% | · | 5.6% | 4.6% | -0.42% | · | 4.7% | 3.1% | 2.0% | · | -0.59% | |
| ROIC | 2.5% | 3.3% | · | 17.2% | -7.4% | -0.49% | · | 2.7% | 2.6% | 5.8% | · | 2.8% | 2.2% | 1.8% | · | 0.08% |
Likuiditas & Solvabilitas 4
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 2.0 | · | 1.7 | 1.6 | 3.4 | · | 4.3 | 2.4 | 2.3 | · | 2.1 | 3.2 | 3.1 | · | 3.2 | |
| Quick Ratio | 1.1 | 1.2 | · | 0.9 | 0.9 | 2.1 | · | 2.9 | 1.3 | 1.4 | · | 1.2 | 2.0 | 2.0 | · | 1.8 | |
| Debt / Equity | 0.9 | 1.2 | · | 1.4 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.7 | · | 2.1 | |
| LT Debt / Equity | 0.7 | 1.0 | · | 1.1 | 1.2 | 1.3 | · | 1.5 | 1.4 | 1.4 | · | 1.5 | 1.6 | 1.7 | · | 2.1 |
Efisiensi 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.3 | · | 1.6 | 1.6 | 1.4 | · | 1.6 | 1.6 | 1.5 | · | 1.7 |
Valuasi (TTM) 13
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.45B | $4.14B | · | $4.12B | $4.02B | $3.88B | · | $3.95B | $3.86B | $3.72B | · | $3.76B | $3.72B | $3.58B | · | $3.53B | |
| Net Income TTM | $19M | $-266M | · | $-345M | $-427M | $276M | · | $516M | $405M | $306M | · | $301M | $189M | $86M | · | $-36M | |
| Market Cap | $15.61B | $11.85B | · | $8.01B | $6.44B | $7.65B | · | $6.73B | $6.59B | $7.59B | · | $8.15B | · | · | · | · | |
| Enterprise Value | $18.35B | $15.36B | · | $12.04B | $10.61B | $11.16B | · | $10.63B | $10.94B | $11.86B | · | $12.53B | · | · | · | · | |
| P/E | -535.5 | -39.8 | · | -22.9 | -14.4 | 29.8 | · | 14.2 | 18.0 | 26.9 | · | 29.5 | 44.3 | 111.7 | · | -225.9 | |
| P/S | 3.5 | 2.9 | · | 1.9 | 1.6 | 2.0 | · | 1.7 | 1.7 | 2.0 | · | 2.2 | · | · | · | · | |
| P/B | 3.3 | 2.6 | · | 2.0 | 1.7 | 1.8 | · | 1.6 | 1.8 | 2.1 | · | 2.3 | · | · | · | · | |
| P / Cash Flow | · | 29.0 | · | · | · | 17.8 | · | · | · | 28.4 | · | · | · | · | · | · | |
| P / FCF | · | 30.5 | · | · | · | 18.4 | · | · | · | 29.2 | · | · | · | · | · | · | |
| EV / EBITDA | 73.9 | 45.6 | · | 209.4 | -15.5 | -199.6 | · | 40.8 | 54.9 | 179.1 | · | 72.7 | · | · | · | · | |
| EV / FCF | · | 39.5 | · | · | · | 26.8 | · | · | · | 45.5 | · | · | · | · | · | · | |
| EV / Revenue | 4.1 | 3.7 | · | 2.9 | 2.6 | 2.9 | · | 2.7 | 2.8 | 3.2 | · | 3.3 | · | · | · | · | |
| Earnings Yield | -0.19% | -2.5% | · | -4.4% | -6.9% | 3.4% | · | 7.0% | 5.5% | 3.7% | · | 3.4% | 2.3% | 0.90% | · | -0.44% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Pendapatan | $4.27B | $4.07B | $3.83B | $3.66B | $3.09B |
| Laba Bersih | $-356M | $560M | $415M | $-224M | $-330M |
| EPS Dilusian | $-5.84 | $8.65 | $6.10 | $-3.58 | $-5.52 |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 690 pengaju · $9.8B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 143 (+46 vs Kuartal sebelumnya) | 56 (-21 vs Kuartal sebelumnya) | 220 (+20 vs Kuartal sebelumnya) | 190 (+12 vs Kuartal sebelumnya) | +4.4M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| FMR LLC | $846.470.147 | 3.512.762 | 8,60% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $731.636.247 | 3.036.213 | 7,43% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $657.763.761 | 2.729.650 | 6,68% | Saham |
| Capital World Investors | $650.043.082 | 2.697.610 | 6,60% | Saham |
| STATE STREET CORP | $481.895.662 | 1.999.816 | 4,89% | Saham |
| FULLER & THALER ASSET MANAGEMENT, INC. | $394.839.917 | 1.638.544 | 4,01% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $390.196.222 | 1.619.274 | 3,96% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $297.928.728 | 1.236.065 | 3,03% | Saham |
| AMERIPRISE FINANCIAL INC | $260.580.996 | 1.081.421 | 2,65% | Saham |
| CITADEL ADVISORS LLC | $242.578.716 | 1.006.676 | 2,46% | Saham |
| Swedbank AB | $233.208.837 | 967.792 | 2,37% | Saham |
| MILLENNIUM MANAGEMENT LLC | $184.072.164 | 763.880 | 1,87% | Saham |
| VICTORY CAPITAL MANAGEMENT INC | $165.478.678 | 686.719 | 1,68% | Saham |
| NORGES BANK | $158.279.458 | 656.843 | 1,61% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $135.442.731 | 562.073 | 1,38% | Saham |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $129.891.746 | 539.037 | 1,32% | Saham |
| Allianz Asset Management GmbH | $122.925.785 | 510.129 | 1,25% | Saham |
| GMT Capital Corp | $109.279.895 | 453.500 | 1,11% | Saham |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $105.278.106 | 436.893 | 1,07% | Saham |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $103.893.734 | 431.148 | 1,06% | Saham |
| TWO SIGMA INVESTMENTS, LP | $96.439.086 | 400.212 | 0,98% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $95.008.929 | 394.277 | 0,96% | Saham |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $89.279.867 | 370.502 | 0,91% | Saham |
| Sofinnova Investments, Inc. | $88.036.221 | 365.341 | 0,89% | Saham |
| Polaris Capital Management, LLC | $79.270.937 | 328.966 | 0,81% | Saham |
| AMERICAN CENTURY COMPANIES INC | $77.695.234 | 322.427 | 0,79% | Saham |
| Bank of New York Mellon Corp | $76.961.481 | 319.382 | 0,78% | Saham |
| GOLDENTREE ASSET MANAGEMENT LP | $70.838.675 | 294.435 | 0,72% | Saham |
| Qube Research & Technologies Ltd | $70.056.003 | 290.725 | 0,71% | Saham |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $66.815.854 | 277.279 | 0,68% | Saham |
| Quantinno Capital Management LP | $65.906.960 | 273.506 | 0,67% | Saham |
| Boston Trust Walden Corp | $64.110.068 | 266.050 | 0,65% | Saham |
| BANK OF AMERICA CORP /DE/ | $60.589.497 | 251.440 | 0,62% | Saham |
| Tri Locum Partners LP | $53.427.868 | 221.720 | 0,54% | Saham |
| Iron Triangle Partners LP | $49.668.900 | 292.170 | 0,50% | Saham |
| ARGENT CAPITAL MANAGEMENT LLC | $48.211.350 | 200.072 | 0,49% | Saham |
| GOLDMAN SACHS GROUP INC | $45.527.185 | 188.933 | 0,46% | Saham |
| PERCEPTIVE ADVISORS LLC | $40.964.900 | 170.000 | 0,42% | Saham |
| RAYMOND JAMES FINANCIAL INC | $39.434.259 | 163.648 | 0,40% | Saham |
| RHUMBLINE ADVISERS | $39.282.382 | 163.018 | 0,40% | Saham |
| Holocene Advisors, LP | $38.794.001 | 160.991 | 0,39% | Saham |
| Saturn V Capital Management LP | $38.781.230 | 160.938 | 0,39% | Saham |
| PFM Health Sciences, LP | $38.740.265 | 160.768 | 0,39% | Saham |
| Retirement Systems of Alabama | $38.473.993 | 159.663 | 0,39% | Saham |
| Woodline Partners LP | $36.165.501 | 150.083 | 0,37% | Saham |
| LOOMIS SAYLES & CO L P | $35.355.338 | 146.721 | 0,36% | Saham |
| Pictet Asset Management Holding SA | $35.115.175 | 147.599 | 0,36% | Saham |
| PRINCIPAL FINANCIAL GROUP INC | $34.163.762 | 141.776 | 0,35% | Saham |
| STIFEL FINANCIAL CORP | $33.583.066 | 139.365 | 0,34% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $33.026.625 | 137.057 | 0,34% | Saham |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $32.383.478 | 134.388 | 0,33% | Saham |
| California Public Employees Retirement System | $30.759.098 | 127.647 | 0,31% | Saham |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $30.249.134 | 160.006 | 0,31% | Saham |
| Robeco Institutional Asset Management B.V. | $28.340.967 | 117.612 | 0,29% | Saham |
| Gotham Asset Management, LLC | $26.992.014 | 112.014 | 0,27% | Saham |
| Aristotle Capital Management, LLC | $26.915.626 | 111.697 | 0,27% | Saham |
| Swiss National Bank | $26.771.767 | 111.100 | 0,27% | Saham |
| STOREBRAND ASSET MANAGEMENT AS | $26.309.828 | 109.183 | 0,27% | Saham |
| CANADA PENSION PLAN INVESTMENT BOARD | $25.928.372 | 107.600 | 0,26% | Saham |
| PANAGORA ASSET MANAGEMENT INC | $25.286.187 | 104.935 | 0,26% | Saham |
| BlackRock, Inc. | $23.889.284 | 99.138 | 0,24% | Saham |
| Perpetual Ltd | $23.733.376 | 98.491 | 0,24% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $23.658.917 | 98.182 | 0,24% | Saham |
| MORGAN STANLEY | $23.519.795 | 97.604 | 0,24% | Saham |
| Man Group plc | $23.299.389 | 96.690 | 0,24% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $22.868.053 | 94.900 | 0,23% | Opsi jual |
| ENVESTNET ASSET MANAGEMENT INC | $22.061.835 | 91.554 | 0,22% | Saham |
| Rhenman & Partners Asset Management AB | $21.070.417 | 87.440 | 0,21% | Saham |
| Aberdeen Group plc | $20.146.538 | 83.606 | 0,20% | Saham |
| Amundi | $19.114.464 | 79.323 | 0,19% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18.916.145 | 78.500 | 0,19% | Opsi beli |
| Schonfeld Strategic Advisors LLC | $18.620.232 | 77.272 | 0,19% | Saham |
| FIRST TRUST ADVISORS LP | $18.149.860 | 75.320 | 0,18% | Saham |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $17.765.513 | 73.725 | 0,18% | Saham |
| LAZARD ASSET MANAGEMENT LLC | $16.768.620 | 69.588 | 0,17% | Saham |
| Longaeva Partners L.P. | $16.576.808 | 68.792 | 0,17% | Saham |
| Simplify Asset Management Inc. | $16.520.903 | 68.560 | 0,17% | Saham |
| ALLIANCEBERNSTEIN L.P. | $16.497.448 | 87.265 | 0,17% | Saham |
| Distillate Capital Partners LLC | $16.167.159 | 67.092 | 0,16% | Saham |
| SEB Asset Management AB | $15.890.255 | 65.943 | 0,16% | Saham |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $15.380.484 | 64.700 | 0,16% | Saham |
| SEI INVESTMENTS CO | $14.931.224 | 61.963 | 0,15% | Saham |
| Illinois Municipal Retirement Fund | $14.911.947 | 61.883 | 0,15% | Saham |
| Tweedy, Browne Co LLC | $14.494.105 | 60.149 | 0,15% | Saham |
| MARTINGALE ASSET MANAGEMENT L P | $14.335.788 | 59.492 | 0,15% | Saham |
| DeepCurrents Investment Group LLC | $14.132.168 | 58.647 | 0,14% | Saham |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $13.348.774 | 55.396 | 0,14% | Saham |
| VANGUARD ASSET MANAGEMENT, Ltd | $12.952.138 | 53.750 | 0,13% | Saham |
| ExodusPoint Capital Management, LP | $12.819.845 | 53.201 | 0,13% | Saham |
| Squarepoint Ops LLC | $12.807.074 | 53.148 | 0,13% | Saham |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $12.034.356 | 63.657 | 0,12% | Saham |
| ALGERT GLOBAL LLC | $11.749.697 | 48.760 | 0,12% | Saham |
| CASTLEARK MANAGEMENT LLC | $11.306.312 | 46.920 | 0,11% | Saham |
| CITADEL ADVISORS LLC | $11.253.299 | 46.700 | 0,11% | Opsi beli |
| RENAISSANCE GROUP LLC | $11.221.601 | 46.568 | 0,11% | Saham |
| Nuveen, LLC | $11.184.623 | 46.415 | 0,11% | Saham |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $10.859.795 | 45.067 | 0,11% | Saham |
| Foundry Partners, LLC | $10.730.160 | 86.429 | 0,11% | Saham |
| Legal & General Group Plc | $10.402.916 | 43.171 | 0,11% | Saham |
| DEAN INVESTMENT ASSOCIATES, LLC | $10.273.274 | 42.633 | 0,10% | Saham |
Orang dalam perusahaan 50 orang dalam · 4 pejabat · 4 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Renee D Gala | President & CEO | 30 Juni 2026 F | 147.361 | 0 | 0 | $0 |
| Philip L Johnson | EVP & Chief Financial Officer | 30 Juni 2026 F | 56.431 | 0 | 0 | $0 |
| Neena M Patil | EVP & Chief Legal Officer | 30 Juni 2026 F | 48.871 | 0 | 2 | $-560.664 |
| Robert Iannone | EVP, Global Head of R&D & CMO | 30 Juni 2026 F | 85.107 | 0 | 0 | $0 |
| Bryan C Cressey | Direktur | 9 Maret 2012 S | 27.631 | 0 | 0 | $0 |
| Zilkha M Nathaniel | Direktur | 10 Maret 2011 A | — | 0 | 0 | $0 |
| Alexander E Albert | Direktur | 15 Agu 2008 A | — | 0 | 0 | $0 |
| Patel Jaimin | Direktur | 15 Agu 2007 A | — | 0 | 0 | $0 |
| Patrick Kennedy | — | 5 Agu 2026 A | 8.307 | 0 | 0 | $0 |
| Samantha Pearce | — | 5 Agu 2026 F | 47.131 | 0 | 1 | $-1.625.977 |
| Mark Douglas Smith | — | 5 Agu 2026 A | 11.285 | 0 | 1 | $-266.746 |
| Jennifer E. Cook | — | 5 Agu 2026 A | 12.442 | 0 | 0 | $0 |
| Laura Hamill | — | 5 Agu 2026 A | 8.538 | 0 | 0 | $0 |
| Heather Ann Mcsharry | — | 5 Agu 2026 A | 20.054 | 0 | 0 | $0 |
| Seamus Mulligan | — | 5 Agu 2026 A | 1.184.633 | 0 | 0 | $0 |
| Rick E Winningham | — | 5 Agu 2026 A | 11.172 | 0 | 2 | $-1.656.873 |
| Patrick G. Enright | — | 5 Agu 2026 A | 22.984 | 0 | 0 | $0 |
| Bruce C Cozadd | — | 5 Agu 2026 A | 362.287 | 0 | 20 | $-25.646.326 |
| Ted W Love | — | 5 Agu 2026 A | 3.132 | 0 | 0 | $0 |
| Norbert G Riedel | — | 5 Agu 2026 A | 8.629 | 0 | 1 | $-655.680 |
| Kenneth W O'Keefe | — | 2 Des. 2025 F | 25.811 | 0 | 0 | $0 |
| Daniel N Swisher JR | — | 3 Jan. 2019 F | 16.512 | 0 | 0 | $0 |
| Suzanne Sawochka Hooper | — | 14 Des. 2018 M | 41.184 | 0 | 0 | $0 |
| Matthew P. Young | — | 23 Nov. 2018 S | 32.068 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | — | 13 Nov. 2018 S | 24.972 | 0 | 0 | $0 |
| Paul Treacy | — | 10 Agu 2018 S | 17.458 | 0 | 0 | $0 |
| Elmar Schnee | — | 9 Agu 2018 A | 6.094 | 0 | 0 | $0 |
| Peter Gray | — | 9 Agu 2018 A | 8.182 | 0 | 0 | $0 |
| Catherine A. Sohn | — | 9 Agu 2018 A | 7.654 | 0 | 0 | $0 |
| Paul L Berns | — | 9 Agu 2018 A | 6.772 | 0 | 0 | $0 |
| Karen J Wilson | — | 11 Mei 2018 S | 15.757 | 0 | 0 | $0 |
| Karen L. Smith | — | 5 Maret 2018 F | 28.474 | 0 | 0 | $0 |
| Iain Mcgill | — | 5 Maret 2018 F | 22.048 | 0 | 0 | $0 |
| Russell J. Cox | — | 6 Maret 2017 F | 52.795 | 0 | 0 | $0 |
| Jeffrey K Tobias | — | 5 Maret 2015 F | 38.484 | 0 | 0 | $0 |
| Fintan Keegan | — | 8 Juli 2014 M | 31.750 | 0 | 0 | $0 |
| Kathryn E Falberg | — | 5 Maret 2014 F | 133.387 | 0 | 0 | $0 |
| James C Momtazee | — | 13 Agu 2013 S | 17.315 | 0 | 0 | $0 |
| Carol A Gamble | — | 9 Maret 2012 S | 32.213 | 0 | 0 | $0 |
| Alan Sebulsky | — | 9 Maret 2012 S | 54.355 | 0 | 0 | $0 |
| Samuel D Colella | — | 11 Jan. 2012 M | 38.347 | 0 | 0 | $0 |
| Michael W Michelson | — | 11 Jan. 2012 M | 13.885 | 0 | 0 | $0 |
| Mark G. Eller | — | 13 Agu 2011 M | 4.151 | 0 | 0 | $0 |
| Michael A. Desjardin | — | 13 Agu 2011 M | 14.574 | 0 | 0 | $0 |
| Janne Lt Wissel | — | 31 Mei 2011 J | 48.544 | 0 | 0 | $0 |
| Joan Colligan | — | 30 Nov. 2010 J | 14.424 | 0 | 0 | $0 |
| Robert M Myers | — | 30 Nov. 2010 J | 156.898 | 0 | 0 | $0 |
| James B Tananbaum | — | 25 Agu 2010 A | 21.366 | 0 | 0 | $0 |
| Samuel R Saks | — | 21 Jan. 2009 A | 358.868 | 0 | 0 | $0 |
| Matthew K Fust | — | 28 Nov. 2008 J | 58.948 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 6 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals Public Limited Company, Jazz Financing I Limited, Jazz Investments II Limited, Jazz Pharmaceuticals Italy S.p.A. ×4 pengajuan | 20 Juni 2014 | — | Pengajuan awal | — | SEC |
| KKR JP LLC, KKR Millennium Fund L.P., KKR Associates Millennium L.P., KKR Millennium GP LLC, KKR Fund Holdings L.P., KKR Fund Holdings GP Limited, KKR Group Holdings L.P., KKR Group Limited, KKR & Co. L.P., KKR Management LLC, KKR JP III LLC, KKR Partners III, L.P., KKR III GP LLC, Henry R. Kravis, George R. Roberts ×3 pengajuan | 12 Maret 2013 | — | Pengajuan awal | — | SEC |
| Longitude Capital Partners, LLC, Longitude Venture Partners, L.P., Longitude Capital Associates, L.P., Patrick G. Enright, Juliet Tammenoms Bakker ×3 pengajuan | 14 Maret 2012 | — | Pengajuan awal | Struktur modal | SEC |
| Longitude Capital Partners, LLC (2), Longitude Venture Partners, L.P. (2), Longitude Capital Associates, L.P. (2), Patrick G. Enright (2), Juliet Tammenoms Bakker (2) ×3 pengajuan | 30 Sep. 2011 | — | Pengajuan awal | — | SEC |
| Azur Pharma Limited | 28 Sep. 2011 | — | Pengajuan awal | — | SEC |
| Jazz Pharmaceuticals, Inc., KKR Millennium Fund L.P., KKR Associates Millennium L.P., KKR Millennium GP LLC, KKR Partners III, L.P., KKR III GP LLC, KKR JP LLC, KKR JP III LLC | 28 April 2005 | — | Pengajuan awal | M&A / penjualan | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 72 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| IHE · iShares Trust | 3,55% | 224.123 SH | 8 Agu 2026 | Harian |
| PJP · Invesco Exchange-Traded Fund Trust | 2,75% | 54.246 SH | 8 Agu 2026 | Harian |
| PTH · Invesco Exchange-Traded Fund Trust | 1,88% | 18.101 SH | 8 Agu 2026 | Harian |
| PILL · Direxion Shares ETF Trust | 1,47% | 931 NS | 30 April 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1,10% | 3.412 SH | 8 Agu 2026 | Harian |
| RFG · Invesco Exchange-Traded Fund Trust | 1,01% | 14.167 SH | 8 Agu 2026 | Harian |
| IJK · iShares Trust | 0,86% | 367.117 SH | 8 Agu 2026 | Harian |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,79% | 61.910 SH | 8 Agu 2026 | Harian |
| PDP · Invesco Exchange-Traded Fund Trust | 0,64% | 37.430 SH | 8 Agu 2026 | Harian |
| XJH · iShares Trust | 0,51% | 8.479 SH | 8 Agu 2026 | Harian |
| ISCV · iShares Trust | 0,50% | 13.756 SH | 8 Agu 2026 | Harian |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0,50% | 14.803 NS | 30 April 2026 | N-PORT |
| AVMV · AMERICAN CENTURY ETF TRUST | 0,49% | 12.809 NS | 31 Mei 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,48% | 8.322 SH | 8 Agu 2026 | Harian |
| IJH · iShares Trust | 0,44% | 2.164.793 SH | 8 Agu 2026 | Harian |
| SMMV · iShares Trust | 0,41% | 4.673 SH | 8 Agu 2026 | Harian |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,41% | 101.353 SH | 8 Agu 2026 | Harian |
| VFVA · VANGUARD WELLINGTON FUND | 0,32% | 11.363 SH | 8 Agu 2026 | Harian |
| VBR · VANGUARD INDEX FUNDS | 0,31% | 867.777 SH | 8 Agu 2026 | Harian |
| AVLV · AMERICAN CENTURY ETF TRUST | 0,28% | 154.718 NS | 31 Mei 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,28% | 8.083 SH | 8 Agu 2026 | Harian |
| IYH · iShares Trust | 0,25% | 35.721 SH | 8 Agu 2026 | Harian |
| ISCB · iShares Trust | 0,25% | 2.794 SH | 8 Agu 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,25% | 169.973 NS | 30 April 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,24% | 1.006 NS | 30 April 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,24% | 19.561 SH | 8 Agu 2026 | Harian |
| NUSC · Nushares ETF Trust | 0,23% | 14.796 NS | 30 April 2026 | N-PORT |
| ESML · iShares Trust | 0,23% | 25.562 SH | 8 Agu 2026 | Harian |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,20% | 3.508 NS | 31 Mei 2026 | N-PORT |
| SMMD · iShares Trust | 0,20% | 29.882 SH | 8 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,20% | 166.548 SH | 8 Agu 2026 | Harian |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,20% | 10.307 SH | 8 Agu 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,17% | 719.903 SH | 8 Agu 2026 | Harian |
| VB · VANGUARD INDEX FUNDS | 0,17% | 1.366.973 SH | 8 Agu 2026 | Harian |
| DFAT · Dimensional ETF Trust | 0,17% | 113.983 NS | 30 April 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,16% | 59.597 NS | 30 April 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,15% | 1.679 NS | 31 Mei 2026 | N-PORT |
| IWS · iShares Trust | 0,15% | 89.654 SH | 8 Agu 2026 | Harian |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,14% | 59 NS | 31 Mei 2026 | N-PORT |
| WSML · iShares Trust | 0,13% | 3.473 SH | 8 Agu 2026 | Harian |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,13% | 2.492 NS | 31 Mei 2026 | N-PORT |
| IWR · iShares Trust | 0,11% | 243.081 SH | 8 Agu 2026 | Harian |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 3.276 SH | 8 Agu 2026 | Harian |
| XT · iShares Trust | 0,09% | 13.696 SH | 8 Agu 2026 | Harian |
| AVLC · AMERICAN CENTURY ETF TRUST | 0,08% | 4.239 NS | 31 Mei 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,08% | 42.911 NS | 31 Mei 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,07% | 2.294 NS | 31 Mei 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,07% | 147.813 NS | 30 April 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,06% | 45.962 NS | 30 April 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,05% | 7.081 NS | 30 April 2026 | N-PORT |